✦ LIBER ✦

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

✍ Scribed by John J Kavanagh; Charles F Levenback; Pedro T Ramirez; Judith L Wolf; Carla L Moore; Marsha R Jones; Lisa Meng; Gail L Brown; Robert C Bast

Book ID: 119913604
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 404 KB
Volume: 3
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-3-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1/2 Study of Atrasentan Combined w

Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

✍ Witteveen, Petronella O.; van der Mijn, Koen J.C.; Los, Maartje; Kronemeijer, Ro 📂 Article 📅 2010 🏛 Neoplasia Press 🌐 English ⚖ 147 KB

Evaluation of Pegylated Liposomal Doxoru

Evaluation of Pegylated Liposomal Doxorubicin in the Treatment Of Both Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer

✍ Hao Lin; Chih-Wen Tseng; Hung-Yaw Chang; Hsien-Ming Lu; Yu-Che Ou; Chan-Chao Cha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Phase 3 randomised study of canfosfamide

Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer

✍ I. Vergote; N. Finkler; J. del Campo; A. Lohr; J. Hunter; D. Matei; J. Kavanagh; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Phase II study of the combination of peg

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Gemcitabine and pegylated liposomal doxo

Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma

✍ Dimitrios Pectasides; Nicolaos Xiros; George Papaxoinis; Gerasimos Aravantinos; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Retrospective comparative study of irino

Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma

✍ Ichikawa, Ryoko; Torii, Yutaka; Oe, Shuko; Kawamura, Kyoko; Kato, Rina; Hasegawa 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 216 KB